BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287
52 results:

  • 1. Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices.
    Symecko H; Schnoll R; Beidas RS; Bekelman JE; Blumenthal D; Bauer AM; Gabriel P; Boisseau L; Doucette A; Powers J; Cappadocia J; McKenna DB; Richardville R; Cuff L; Offer R; Clement EG; Buttenheim AM; Asch DA; Rendle KA; Shelton RC; Fayanju OM; Wileyto EP; Plag M; Ware S; Shulman LN; Nathanson KL; Domchek SM
    Implement Sci; 2023 Nov; 18(1):57. PubMed ID: 37932730
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for developing breast cancer.
    Diep CH; Mauro LJ; Lange CA
    Steroids; 2023 Dec; 200():109329. PubMed ID: 37884178
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging.
    Wang Y; Zhang H; Wang T; Yao L; Zhang G; Liu X; Yang G; Yuan L
    Sci Rep; 2023 Feb; 13(1):2770. PubMed ID: 36797331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of Physician Densities and Gynecologic cancer Outcomes in the United States.
    Smick AH; Holbert M; Neff R
    Obstet Gynecol; 2022 Nov; 140(5):751-757. PubMed ID: 36201771
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hereditary Breast and ovarian cancer: An Updated Primer for OB/GYNs.
    Bellcross CA
    Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lapses in breast cancer screening for highly penetrant mutation carriers during pregnancy and lactation.
    Chichura A; Hunt J; Lang J; Pederson H
    J Surg Oncol; 2022 Mar; 125(4):589-595. PubMed ID: 34855221
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls.
    Ortega MT; McGrath JA; Carlson L; Flores Poccia V; Larson G; Douglas C; Sun BZ; Zhao S; Beery B; Vesper HW; Duke L; Botelho JC; Filie AC; Shaw ND
    J Clin Endocrinol Metab; 2021 May; 106(6):1668-1683. PubMed ID: 33630047
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study.
    Millien C; Manzi A; Katz AM; Gilbert H; Smith Fawzi MC; Farmer PE; Mukherjee J
    Int J Equity Health; 2021 Jan; 20(1):1. PubMed ID: 33386078
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage.
    Huang JW; Acharya A; Taglialatela A; Nambiar TS; Cuella-Martin R; Leuzzi G; Hayward SB; Joseph SA; Brunette GJ; Anand R; Soni RK; Clark NL; Bernstein KA; Cejka P; Ciccia A
    Nat Commun; 2020 Jun; 11(1):2948. PubMed ID: 32528060
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Endometrial expression of anti-Müllerian hormone and its type II receptor in women with polycystic ovary syndrome.
    Paulson M; Sahlin L; Hirschberg AL
    Reprod Biomed Online; 2020 Jul; 41(1):128-137. PubMed ID: 32444258
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).
    Zeinomar N; Knight JA; Genkinger JM; Phillips KA; Daly MB; Milne RL; Dite GS; Kehm RD; Liao Y; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; MacInnis RJ; Hopper JL; Terry MB
    Breast Cancer Res; 2019 Nov; 21(1):128. PubMed ID: 31779655
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
    Wilhite AM; Oestreich MC; Olson M; Bedell SM; Westenberg D; Bangdiwala A; Ikramuddin S; Sanchez-Avila M; Madoff RD; Khalifa MA; Erickson BK
    Obstet Gynecol; 2019 Sep; 134(3):520-526. PubMed ID: 31403600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
    Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI
    Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Practices and knowledge of female gynecologists regarding contraceptive use: a real-world Chinese survey.
    Yang X; Li X; Wang Y; He X; Zhao Y
    Reprod Health; 2018 Jun; 15(1):115. PubMed ID: 29940973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
    Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
    BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    J Cell Biochem; 2018 Feb; 119(2):2333-2344. PubMed ID: 28885729
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
    Sakhuja S; Yun H; Pisu M; Akinyemiju T
    J Ovarian Res; 2017 Aug; 10(1):57. PubMed ID: 28830564
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.